Canadian Legislation

cooltext1450411940 (1)
12/3/2014

Senate Unanimously Passes Elizabeth May’s Federal Framework on Lyme Disease Act

OTTAWA – Elizabeth May’s Private Member’s Bill, C-442, the Federal Framework on Lyme Disease Act, was passed unanimously at third reading by the Senate the morning of Friday, December 12. The bill now awaits Royal Assent by the Governor General for it to become law.

“I am so thankful to my colleagues in the Senate, especially the bill’s sponsor Senator Janis Johnson, for passing C-442,” said Elizabeth May, Leader of the Green Party of Canada and MP for Saanich-Gulf Islands. “This victory belongs to all Canadians coping with Lyme disease and their loved ones. This bill never would have been passed into law without their advocacy and willingness to tell their stories.”

First introduced in June 2012, Bill C-442 was passed unanimously with multi-partisan support in the House of Commons in June 2014. It will establish a framework for collaboration between the federal, provincial and territorial Health Ministers, representatives of the medical community, and patients’ groups to promote greater awareness and prevention of Lyme disease, to address the challenges of timely diagnosis and treatment, and to push for further research.”

Elizabeth May Testimony at Senate Committee on Federal Framework on Lyme Disease Act

Elizabeth May testifies before the Senate Committee on Social Affairs, Science and Technology regarding her Private Member’s Bill C-442, the National Lyme Disease Strategy Act, on December 3, 2014.

 

cooltext1450435045

Lyme Disease Bill discussion going forward TOMORROW (Oct 22, 2014)

Elizabeth May, Leader of the Green Party of Canada and Member of Parliament for Saanich­Gulf Islands, will testify before the Senate Standing Committee on Social Affairs, Science and Technology tomorrow as the sponsor of Bill C-442, An Act respecting a Federal Framework on Lyme Disease.

cooltext1450435045

 

We have passed our Lyme Bill in Canadian Parliament! Here is the last interview before the Bill passed on June 15, 2014. We are now officially Lyme friendly in Canada, but the consultations have yet to come.https://www.youtube.com/watch?v=FvgarxpithU

 

cooltext14504350452/27/2014
“Bill C-442 will be going to Second Reading debate on Monday, March 3, 2014. I hope all Canadians will read the bill, and ignore efforts to distort its very sensible, scientifically sound approach. With non-partisan, and compassionate support, we can get the bill to committee and consider any changes that meet the concerns of all impacted by what can be a tragic illness.”
Read More on Meerkat’s Heap

cooltext1450435045

 

February 11, 2014
WE NEED YOUR HELP.

Original document in PDF format: CLICK

Today, Elizabeth May is asking for your help in making a difference in the lives of tens of thousands of Canadians. On March 4th, 2014, the House of Commons will begin debate on my Private Members’ Bill, C-442, an Act to Create a National Lyme Disease Strategy.

Many of you are already too aware of the shortcomings of the Canadian medical system in dealing with Lyme. And while not a panacea, Bill C-442, if passed, would bring together Canada’s Health Ministers, medical professionals, scientists, and the advocates for Canadians with Lyme Disease to work toward common goals: increasing awareness and prevention, ensuring accurate diagnoses, tracking the spread of the disease, and establishing national standards for the care and treatment of Lyme that reflect best practices.

We need you to help make sure that this Bill becomes law. Members of Parliament will be back home in their communities during the week of February 17th and, during this time, we are asking you to meet with your MP to share your story, help educate them about Lyme, and explain to them why Canada urgently needs a National Lyme Disease Strategy. Please go to www.greenparty.ca/lyme-disease to call your MP and schedule a meeting during the February 17th constituency week.
Keep Reading Article Here

Share This
Pin on PinterestShare on FacebookTweet about this on TwitterShare on StumbleUponShare on Google+

Leave a Reply

Your email address will not be published.